Unichem Laboratories Limited (NSE:UNICHEMLAB)
503.05
-3.95 (-0.78%)
Aug 29, 2025, 3:29 PM IST
Unichem Laboratories Revenue
Unichem Laboratories had revenue of 5.27B INR in the quarter ending June 30, 2025, with 17.96% growth. This brings the company's revenue in the last twelve months to 21.54B, up 24.66% year-over-year. In the fiscal year ending March 31, 2025, Unichem Laboratories had annual revenue of 21.11B with 18.25% growth.
Revenue (ttm)
21.54B
Revenue Growth
+24.66%
P/S Ratio
1.64
Revenue / Employee
6.86M
Employees
3,142
Market Cap
35.33B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 21.11B | 3.26B | 18.25% |
Mar 31, 2024 | 17.85B | 4.42B | 32.92% |
Mar 31, 2023 | 13.43B | 731.90M | 5.76% |
Mar 31, 2022 | 12.70B | 346.97M | 2.81% |
Mar 31, 2021 | 12.35B | 1.31B | 11.91% |
Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sun Pharmaceutical Industries | 537.77B |
Divi's Laboratories | 96.52B |
Cipla | 274.80B |
Apollo Hospitals Enterprise | 225.51B |
Mankind Pharma | 129.10B |
Zydus Lifesciences | 236.08B |
Fortis Healthcare | 80.94B |
Alkem Laboratories | 133.04B |
Unichem Laboratories News
- 2 months ago - Unichem Laboratories shares drop 4% after USFDA flags 3 procedural issues at Roha facility - Business Upturn
- 3 months ago - Unichem Labs Q4 Results: Revenue up 27.9% YoY to Rs 587.18 crore, company swings back to net profit - Business Upturn
- 3 months ago - Unichem Laboratories receives USFDA EIR for Pithampur facility; inspection classified as VAI - Business Upturn
- 5 months ago - Unichem Laboratories shares rise 2.35% as API plant expansion boosts production capacity - Business Upturn
- 5 months ago - Unichem Laboratories completes Phase I expansion of API plant at Pithampur with Rs 200 crore investment - Business Upturn
- 7 months ago - Unichem Laboratories Q3 results: Revenue rises 14.4% YoY to Rs 533 crore, Net profit falls 21% YoY - Business Upturn